BioNTech pays $170M for 2 drug assets

The latest stories trending on MedCity News.

Editor's Pick

Top Story BioNTech Buys Into Hot Area of Cancer R&D, Paying $170M for 2 Drug Assets BioNTech's alliance with DualityBio gives it two antibody drug conjugate (ADC) candidates, the most advanced of which is in mid-stage clinical development for solid tumors. It addresses the same target as a potential blockbuster AstraZeneca drug. Here's Why You Should Attend INVEST 2023 "I often find the more targeted industry events provide an environment very conducive to connecting with others. MedCity INVEST definitely falls in that category for me. My most recent angel investment came through a contact first made (and subsequent relationship developed) at the INVEST conference. A big thank you to the MedCity team!" ~ G. Winokur, Angel Investor Early Bird Savings of $400 Ends Friday - Register Now!

Featured News

FTC Orders Illumina to Divest Grail, Says Deal Stifles Cancer Test Competition The Federal Trade Commission has ordered Illumina to divest Grail, the liquid biopsy company it acquired for more than $7 billion. The agency said Illumina's proposed remedies are insufficient and the tie-up is likely to reduce competition in the R&D and commercialization of new cancer tests. Stop, Drop and Reenroll: How Medicaid Redeterminations, Renewals, and Disenrollment Can Affect the Revenue Cycle Florida healthcare providers are prone to experience unpredictable changes in the revenue cycle when Medicaid plans begin the redetermination, renewal, and disenrollment process. 'Don't Be Creepy': How Health Systems Can Help Build Patients' Trust in New Tech As health systems roll out new patient-facing technologies, they need to ensure that their patients are comfortable using these tools. To avoid losing patient trust, hospitals should introduce new technology with transparency and patient education at the forefront of their minds, said Aaron Miri, Baptist Health's chief digital and information officer. The Role of AI in Addressing the Maternal Health Crisis Over 800 women died from pregnancy-related complications in 2020 in the United States, and well […] 3 Tech Adoption Rules for Health Systems to Follow Hospitals are being more careful than ever when scrutinizing ROI for new technology. Ashis Barad — Allegheny Health Network's chief information and digital officer — gave advice for health systems follow during the adoption process for new technology, such as ensuring clinicians are involved early on and viewing Big Tech as partners instead of threats. Aggregate Data to Improve Patient Safety: How Data Can Inform Risk Management Data can help healthcare facilities improve patient safety, but first, healthcare leaders need to bring data from multiple sources together using a common taxonomy.

Resources

MedCity Moves Podcast: Recent Hires and Layoffs In this month's episode, we dive into some of the recent executive appointments occurring in the healthcare sector, as well as layoffs affecting the industry. We also hear from Tom Richards, who recently became the new executive vice president of business development at Transcarent after spending more than 35 years at Cigna. Listen Now

MedCity News • 611 Broadway • New York, NY unsubscribe